Supreme Court declines relief to Zydus Lifesciences in breast cancer drug case

Share it

Zydus had approached the Supreme Court challenging the Delhi High Court’s order, which prevented the company from producing and marketing breast cancer drug Sigrima.

Leave a Comment

Your email address will not be published. Required fields are marked *